Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particles
- 1 September 2000
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 7 (17) , 1477-1482
- https://doi.org/10.1038/sj.gt.3301263
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 19 references indexed in Scilit:
- Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccineJournal of General Virology, 2000
- The molecular pathogenesis of Semliki Forest virus: a model virus made useful?Journal of General Virology, 1999
- The Semliki Forest virus vector induces p53-independent apoptosis.Journal of General Virology, 1998
- Death mechanisms in cultured cells infected by Semliki Forest virus.Journal of General Virology, 1997
- Cancer gene therapy using a novel adeno-associated virus vector expressing human wild-type p53Gene Therapy, 1997
- DNA VACCINESAnnual Review of Immunology, 1997
- Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.Nature Medicine, 1996
- Therapeutic Effect of a Retroviral Wild-Type p53 Expression Vector in an Orthotopic Lung Cancer ModelJNCI Journal of the National Cancer Institute, 1994
- p53: A Frequent Target for Genetic Abnormalities in Lung CancerScience, 1989
- Cell and Environment Interactions in Tumor Microregions: The Multicell Spheroid ModelScience, 1988